CS logo
small CS logo
Universitätsfrauenklinik Köln

Koln, Germany
Obstetrician-gynecologist in Cologne, North Rhine-Westphalia
Kerpener Str. 62, 50937 Köln

About Universitätsfrauenklinik Köln


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AGO Research GmbH
1
Arcagy Research
1
Genentech, Inc.
1
Hoffmann-La Roche
1
Total Rows: 4

Clinical Trials at Universitätsfrauenklinik Köln


During the past decade, Universitätsfrauenklinik Köln conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001100000011Started TrialsCompleted Trails201520162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Platine, Avastin and OLAparib in 1st Line
2015-05-06
2022-03-22
Completed
806
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
2018-09-11
2024-12-01
Active, not recruiting
550

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsfrauenklinik Köln" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAGO Research GmbH: 1AGO Research GmbH: 1Arcagy Research: 1Arcagy Research: 1Genentech, Inc.: 1Genentech, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsHoffmann-La Roche: 2Hoffmann-La Roche: 2ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologisheOnkologie Germany: 1ArbeitsgemeinschaftGynaekologisheOnkologie Germany: 1Belgian GynaecologicalOncology Group: 1Belgian GynaecologicalOncology Group: 1Breast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1Grupo Español deInvestigación en Cáncerde Ovario: 1Grupo Español deInvestigación en Cáncerde Ovario: 1Gynecologic OncologyTrial & InvestigationConsortium: 1Gynecologic OncologyTrial & InvestigationConsortium: 1Mario NegriGynecologic Oncologygroup (MaNGO): 1Mario NegriGynecologic Oncologygroup (MaNGO): 1Multicenter Italian Trialsin Ovarian cancer andgynecologicmalignancies: 1Multicenter Italian Trialsin Ovarian cancer andgynecologicmalignancies: 1

Clinical Trials Conditions at Universitätsfrauenklinik Köln


According to Clinical.Site data, the most researched conditions in "Universitätsfrauenklinik Köln" are "Breast Cancer" (1 trials), "Neoplasm Metastasis" (1 trials), "Ovarian Cancer" (1 trials) and "Recurrent Ovarian Carcinoma" (1 trials). Many other conditions were trialed in "Universitätsfrauenklinik Köln" in a lesser frequency.

Clinical Trials Intervention Types at Universitätsfrauenklinik Köln


Most popular intervention types in "Universitätsfrauenklinik Köln" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Universitätsfrauenklinik Köln


The vast majority of trials in "Universitätsfrauenklinik Köln" are 2 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Universitätsfrauenklinik Köln


Currently, there are NaN active trials in "Universitätsfrauenklinik Köln". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsfrauenklinik Köln, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsfrauenklinik Köln, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 2Active, not recruiting: 2Completed: 1Completed: 1Recruiting: 1Recruiting: 1